 |
Dr Reem Alsulaiman |
| Chairperson, Medical Genetics Department American Board-Certified Sr. Consultant, Genetic Counseling Assistant Professor, Hamad Medical Corporation |
| Dr Reem is the Chairperson of the Medical Genetics Department at Hamad Medical Corporation and an American Board-Certified Sr. Consultant Genetic Counselor with expertise in cancer genetics and rare diseases. In addition, Dr Reem is the Vice President of Qatar Network of Medical Genetics and the Assistant Chair of the Doha-Heidelberg Rare Disease MDT and Research Committee and contributes as a member at the Qatar Precision Health Institute (QPHI) committees. |
| In addition to her clinical and leadership roles, Dr Reem is also Assistant Professor and respected teaching faculty at the Qatar University's national genetic counseling program and she the main establisher of the genetic counseling profession's licensing and profession's hierarchy in Qatar. Dr. Reem had completed her clinical training and fellowship in genetic counseling from Sarah Lawrence College in New York in all clinical subspecialties with special interest in cancer genetics. Dr Reem was trained in multiple prestigious institutions in New York including Memorial Sloan Kettering, New York Presbyterian and Columbia Medical Centre. She then achieved the American board of genetic counselling and became the first Qatari national board-certified genetic counselor in the country. |
| Dr Reem also received her second master degree in cancer therapeutics and achieved her PhD in cancer counselling and psychotherapy from University of Wales, Regents College in London and her research was honored as one of the 100 breakthroughs in the UK in 2018. Dr. Reem has multiple prestigious publications in high impact factor journals in the field of pediatrics and adult clinical genetics with special interest in cancer and rare disorders and is currently leading multiple precision medicine and clinical research projects including the Genomic Newborn Screening national clinical pilot at Hamad Medical Corporation in collaboration with QPHI. |